HAE

Haemonetics Corporation (NASDAQ:HAE) is a Boston-based healthcare company founded in 1971 that specializes in blood and plasma management technologies. The company has evolved from its origins in blood collection to become a leading provider of automated medical devices, software systems, and disposable products that help healthcare providers and plasma collection centers manage blood components more efficiently. Haemonetics went public in 1991 and has since grown through both organic expansion and strategic acquisitions to serve three primary markets: plasma collection, blood centers, and hospitals worldwide.